Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural and biochemical investigation of MARK4 inhibitory potential of cholic acid: Towards therapeutic implications in neurodegenerative diseases
Saleha Anwar, Anas Shamsi, Rajiv K. Kar, et al.
International Journal of Biological Macromolecules (2020) Vol. 161, pp. 596-604
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Discovering potential ERK1 inhibitors from natural products for therapeutic targeting of Alzheimer's disease
Mohammad Taufeeq, Arunabh Choudhury, Afzal Hussain, et al.
Journal of Alzheimer s Disease (2025)
Closed Access | Times Cited: 1
Exploring MTH1 inhibitory potential of Thymoquinone and Baicalin for therapeutic targeting of breast cancer
Aaliya Taiyab, Arunabh Choudhury, Shaista Haidar, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116332-116332
Open Access | Times Cited: 10
Structure‐based investigation of MARK4 inhibitory potential of Naringenin for therapeutic management of cancer and neurodegenerative diseases
Saleha Anwar, Shama Khan, Anas Shamsi, et al.
Journal of Cellular Biochemistry (2021) Vol. 122, Iss. 10, pp. 1445-1459
Closed Access | Times Cited: 53
Therapeutic implications and clinical manifestations of thymoquinone
Manzar Alam, Gulam Mustafa Hasan, Md. Meraj Ansari, et al.
Phytochemistry (2022) Vol. 200, pp. 113213-113213
Closed Access | Times Cited: 30
Investigating MARK4 inhibitory potential of Bacopaside II: Targeting Alzheimer's disease
Saleha Anwar, Taj Mohammad, Md. Khabeer Azhar, et al.
International Journal of Biological Macromolecules (2023) Vol. 245, pp. 125364-125364
Closed Access | Times Cited: 16
Myricetin inhibits breast and lung cancer cells proliferation via inhibiting MARK4
Saleha Anwar, Shama Khan, Farah Anjum, et al.
Journal of Cellular Biochemistry (2021) Vol. 123, Iss. 2, pp. 359-374
Closed Access | Times Cited: 37
Targeting cyclin‐dependent kinase 6 by vanillin inhibits proliferation of breast and lung cancer cells: Combined computational and biochemical studies
Mohd Yousuf, Anas Shamsi, Aarfa Queen, et al.
Journal of Cellular Biochemistry (2021) Vol. 122, Iss. 8, pp. 897-910
Closed Access | Times Cited: 32
Mechanistic Insight into Binding of Huperzine A with Human Serum Albumin: Computational and Spectroscopic Approaches
Anas Shamsi, Moyad Shahwan, Mohd Shahnawaz Khan, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 797-797
Open Access | Times Cited: 23
Molecular mechanism and therapeutic strategy of bile acids in Alzheimer’s disease from the emerging perspective of the microbiota–gut–brain axis
Menglu Wu, Yongyi Cheng, Ruolin Zhang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117228-117228
Open Access | Times Cited: 4
MAP/Microtubule Affinity Regulating Kinase 4 Inhibitory Potential of Irisin: A New Therapeutic Strategy to Combat Cancer and Alzheimer’s Disease
Rashid Waseem, Saleha Anwar, Shama Khan, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 10986-10986
Open Access | Times Cited: 29
Implications of tempol in pyruvate dehydrogenase kinase 3 targeted anticancer therapeutics: Computational, spectroscopic, and calorimetric studies
Saleha Anwar, Debarati DasGupta, Alaa Shafie, et al.
Journal of Molecular Liquids (2022) Vol. 350, pp. 118581-118581
Closed Access | Times Cited: 20
Inhibiting Cyclin-Dependent Kinase 6 by Taurine: Implications in Anticancer Therapeutics
Mohd Yousuf, Anas Shamsi, Taj Mohammad, et al.
ACS Omega (2022) Vol. 7, Iss. 29, pp. 25844-25852
Open Access | Times Cited: 19
Binding Studies of Caffeic and p-Coumaric Acid with α-Amylase: Multispectroscopic and Computational Approaches Deciphering the Effect on Advanced Glycation End Products (AGEs)
Mohd Shahnawaz Khan, Majed S. Alokail, Amal Alenad, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 3992-3992
Open Access | Times Cited: 18
Microtubule-affinity regulating kinase 4: A potential drug target for cancer therapy
Saleha Anwar, Moyad Shahwan, Gulam Mustafa Hasan, et al.
Cellular Signalling (2022) Vol. 99, pp. 110434-110434
Closed Access | Times Cited: 18
In silico investigation and potential therapeutic approaches of isoquinoline alkaloids for neurodegenerative diseases: computer-aided drug design perspective
Riyadh Ahmed Atto Al‐Shuaeeb, H. R. Abd El-Mageed, Shimaa A. Ahmed, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 23, pp. 14484-14496
Closed Access | Times Cited: 11
Cinnamomum zeylanicum Extract and its Bioactive Component Cinnamaldehyde Show Anti-Tumor Effects via Inhibition of Multiple Cellular Pathways
Sadhna Aggarwal, Kanchan Bhadana, Baldeep Singh, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Investigating role of plumbagin in preventing neurodegenerative diseases via inhibiting microtubule affinity regulating kinase 4
Mohd Adnan, Debarati DasGupta, Saleha Anwar, et al.
Journal of Molecular Liquids (2023) Vol. 384, pp. 122267-122267
Closed Access | Times Cited: 8
Probing Baicalin as potential inhibitor of Aurora kinase B: A step towards lung cancer therapy
Saba Noor, Arunabh Choudhury, Ali Raza, et al.
International Journal of Biological Macromolecules (2023) Vol. 258, pp. 128813-128813
Closed Access | Times Cited: 8
Insight into the binding of PEG-400 with eye protein alpha-crystallin: Multi spectroscopic and computational approach: possible therapeutics targeting eye diseases
Anas Shamsi, Taj Mohammad, Saleha Anwar, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 40, Iss. 10, pp. 4496-4506
Closed Access | Times Cited: 22
Mechanistic insights into the pathogenesis of neurodegenerative diseases: towards the development of effective therapy
Fauzia Nazam, Sibhghatulla Shaikh, Nazia Nazam, et al.
Molecular and Cellular Biochemistry (2021) Vol. 476, Iss. 7, pp. 2739-2752
Closed Access | Times Cited: 16
Multispectroscopic and Molecular Docking Insight into Elucidating the Interaction of Irisin with Rivastigmine Tartrate: A Combinational Therapy Approach to Fight Alzheimer’s Disease
Rashid Waseem, Anas Shamsi, Taj Mohammad, et al.
ACS Omega (2021) Vol. 6, Iss. 11, pp. 7910-7921
Open Access | Times Cited: 16
Exploring binding mechanism of naringenin to human transferrin using combined spectroscopic and computational methods: Towards therapeutic targeting of neurodegenerative diseases
Shama Khan, Fahad A. Alhumaydhi, Mohd Shahnawaz Khan, et al.
Journal of Molecular Liquids (2022) Vol. 356, pp. 119001-119001
Closed Access | Times Cited: 11
Identifying repurposed drugs as potential inhibitors of Apolipoprotein E: A bioinformatics approach to target complex diseases associated with lipid metabolism and neurodegeneration
Mohammad Furkan, M. S. Khan, Moyad Shahwan, et al.
International Journal of Biological Macromolecules (2024) Vol. 259, pp. 129167-129167
Closed Access | Times Cited: 1
Synthesis of Some New 1,3,4-Thiadiazole Derivatives Derived from Cholic Acid and Evaluation of their Biological Activity
Intisar Qahtan Mahmood Al-araj, Rana A. Saeed, Linda Reyadh, et al.
Journal of the Turkish Chemical Society Section A Chemistry (2024) Vol. 11, Iss. 2, pp. 425-432
Open Access | Times Cited: 1
Ropinirole reverses the effects of neuroinflammation, and cellular demise by downregulating the MARK4-NFκβ signaling system in Alzheimer's disease
Neha Neha, Saleha Anwar, Pinky Pinky, et al.
International Journal of Biological Macromolecules (2024) Vol. 271, pp. 132425-132425
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top